Catalyst Wire Dossier Catalyst Wire Dossier

SYMPROIC

NALDEMEDINE · BioDelivery Sciences International Inc
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for SYMPROIC, covering 2017-03-23 to 2026-01-02. Get the full timeline:

Most recent: Clinical Trial Update: Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience

See pricing